US Stock MarketDetailed Quotes

GNTA Genenta Science

Watchlist
  • 3.180
  • -0.020-0.63%
Close May 16 16:00 ET
57.93MMarket Cap-4575P/E (TTM)

About Genenta Science Company

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.

Company Profile

SymbolGNTA
Company NameGenenta Science
Listing DateDec 15, 2021
Issue Price11.50
Founded2014
CEOMr. Pierluigi Paracchi
MarketNASDAQ
Employees14
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressVia Olgettina No. 58
CityMilan
ProvinceMilan
CountryItaly
Zip Code20132
Phone39-02-2643-4681
Websitehttp://www.genenta.com

Company Executives

  • Name
  • Position
  • Salary
  • Pierluigi Paracchi
  • Chief Executive Officer, Vice Chairman of the Board and General Manager
  • --
  • Dr. Carlo Russo, M.D.
  • Chief Medical Officer and Head of Development
  • --
  • Richard B. Slansky
  • Chief Financial Officer
  • --
  • Dr. Stefania Mazzoleni, PhD
  • Scientific Project Manager and Communications Officer
  • --
  • Dr. Mark Alan Sirgo, PhD
  • Chairman of the Board
  • --
  • Barbara Regonini
  • Finance Director
  • --
  • Roger Abravanel
  • Independent Director
  • --
  • Guido Angelo Giovanni Guidi
  • Independent Director
  • --
  • Anthony S. Marucci
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg